BNGO Logo.png
Publication Shows Utility of OGM in Solid Tumor Research with Study on Detection of Complex Genomic Rearrangements in Prostate Cancer
21. November 2022 08:00 ET | Bionano Genomics
SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing optical genome mapping (OGM) to detect structural variants...
BNGO Logo.png
Bionano Genomics Appoints Donna Polizio as Its First Ever Global Head of Market Access
10. November 2022 08:00 ET | Bionano Genomics
SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has appointed Donna Polizio as its global head of market access, further strengthening its...
BNGO Logo.png
Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress
03. November 2022 16:01 ET | Bionano Genomics
–  55% year-over-year revenue growth in Q3 2022 –  On track to achieve all 2022 ELEVATE! milestones –  Strong balance sheet with $180.2 million in cash, cash equivalents, and...
BNGO Logo.png
Publication Recommends OGM for Analysis of Hematological Neoplasms Due to Streamlined Structural Variant Detection and High Concordance with Traditional Cytogenetic Methods
03. November 2022 08:00 ET | Bionano Genomics
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the first published validation study to evaluate the performance of optical genome mapping (OGM)...
BNGO Logo.png
Bionano Genomics Announces Extensive Lineup of Content at Association for Molecular Pathology (AMP) Annual Meeting Featuring OGM Utility Across Broad Range of Research Applications
28. Oktober 2022 08:00 ET | Bionano Genomics
Dr. Alka Chaubey, chief medical officer at Bionano, Dr. Nikhil Sahajpal, Greenwood Genetic Center, Dr. Rashmi Kanagal-Shamanna, MD Anderson Cancer Center, and Dr. Adam Smith, University Health Network...
BNGO Logo.png
Bionano Genomics to Report Third Quarter 2022 Financial Results and Host a Conference Call and Webcast on November 3, 2022
27. Oktober 2022 16:01 ET | Bionano Genomics
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, November 3, 2022 at 4:30 p.m. Eastern...
BNGO Logo.png
Hamilton and Bionano Genomics Announce Commercial Availability of World’s First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM
26. Oktober 2022 08:00 ET | Bionano Genomics
SAN DIEGO and RENO, Nev., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the Long String VANTAGE, a system for automated, high throughput...
BNGO Logo.png
Bionano Genomics Announces Global User Event at Bionano Laboratories Before American Society of Human Genetics (ASHG) Annual Meeting
24. Oktober 2022 08:00 ET | Bionano Genomics
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the company will host a “Meet the User” event today, October 24, 2022, at its new CLIA-certified...
BNGO Logo.png
Bionano Genomics Announces Presentation of OGM Utility Across Key Applications at American Society of Human Genetics (ASHG) Annual Meeting
20. Oktober 2022 08:00 ET | Bionano Genomics
Dr. Alka Chaubey, chief medical officer at Bionano, and Dr. Nikhil Sahajpal, fellow at Greenwood Genetic Center, will host a sponsored vendor presentation on a large clinical study utilizing optical...
BNGO Logo.png
OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability to Detect Chromosomal Structural Variations Found in Recurrent Pregnancy Loss
14. Oktober 2022 08:00 ET | Bionano Genomics
SAN DIEGO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a peer-reviewed study evaluating optical genome mapping (OGM) as a method for...